Imperative Care announced the launch of the Ikon 24 Pro guidewire. The next-generation neurovascular guidewire is designed ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...
Xeltis announced the official start of the European commercialization of aXess vascular access device for patients requiring hemod ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
FDA approves a 76-mm version of Abbott’s Esprit BTK resorbable scaffold system for patients with CLTI. The longer scaffold is intended to reduce the number of devices needed to treat long BTK lesions ...
Maintenance of vascular access has long been the Achilles’ heel of patients undergoing hemodialysis (HD). Evolving from the direct cannulation of native vessels to highly morbid Teflon shunts, it wasn ...
Endovascular management of below-the-knee (BTK) arterial disease is increasingly essential due to rising rates of diabetes and peripheral artery disease (PAD) worldwide. Despite technologic advances ...